NCT01182168
- Conditions
- Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +13 more
- Locations
-
- Memorial Sloan Kettering Cancer Center New York, United States
Clinical trial condition
Ureteral Neoplasms
Explore clinical trials studying Ureteral Neoplasms. Study availability and eligibility vary by location and protocol.
63 public trials
14 recruiting studies
Ureteral Neoplasms trial results
NCT00072150
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +22 more
- Locations
-
- UCSF-Mount Zion San Francisco, California, United States
NCT00009867
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, +14 more
- Locations
-
- Cancer and Leukemia Group B Chicago, Illinois, United States
NCT01426126
- Conditions
- Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
- Locations
-
- Asan Medical Center Seoul, South Korea
NCT00661609
- Conditions
- Bladder Cancer, Disease Attributes, Female Urogenital Diseases, +21 more
- Locations
-
- Research Site Palo Alto, California, United States
- Research Site San Bernardino, California, United States
- Research Site Southington, Connecticut, United States
- Research Site Miami, Florida, United States
NCT00101608
- Conditions
- Bladder Cancer, Bladder Neoplasms, Carcinoma, +21 more
- Locations
-
- Local Institution Beverly Hills, California, United States
- Local Institution La Jolla, California, United States
- Local Institution Los Angeles, California, United States
- Local Institution Santa Monica, California, United States
NCT00077688
- Conditions
- Bladder Neoplasms, Carcinoma, Carcinoma, Transitional Cell, +17 more
- Locations
-
- University of Maryland Medical Center/Greenbaum Cancer Center Baltimore, Maryland, United States
- Cleveland Clinic Foundation Cleveland, Ohio, United States
- University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States
NCT00263107
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, +20 more
- Locations
-
- University of California, Davis Sacramento, California, United States
- Johns Hopkins Baltimore, Maryland, United States
- Centerra Health Norfolk, Virginia, United States
Active, Not Recruiting
Testing MK-3475 (Pembrolizumab) After Surgery for Localized Muscle-Invasive Bladder Cancer and Locally Advanced Urothelial Cancer
NCT03244384
- Conditions
- Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Localized Renal Pelvis and Ureter Urothelial Carcinoma, +19 more
- Locations
-
- University of Alabama at Birmingham Cancer Center Birmingham, Alabama, United States
- Anchorage Associates in Radiation Medicine Anchorage, Alaska, United States
- Anchorage Radiation Therapy Center Anchorage, Alaska, United States
- Alaska Breast Care and Surgery LLC Anchorage, Alaska, United States
Active, Not Recruiting
Testing the Addition of the Anti-cancer Drug, Cabozantinib, to the Usual Immunotherapy Treatment, Avelumab, in Patients With Metastatic Urothelial Cancer, MAIN-CAV Study
NCT05092958
- Conditions
- Advanced Bladder Urothelial Carcinoma, Advanced Renal Pelvis Urothelial Carcinoma, Advanced Ureter Urothelial Carcinoma, +30 more
- Locations
-
- Mayo Clinic Hospital in Arizona Phoenix, Arizona, United States
- Sutter Auburn Faith Hospital Auburn, California, United States
- Alta Bates Summit Medical Center-Herrick Campus Berkeley, California, United States
- Palo Alto Medical Foundation-Fremont Fremont, California, United States